P1330: CYTOREDUCTIVE CHEMOTHERAPY COULD ACCELERATE THE LOSS OF CLONAL DIVERSITY IN HEMATOPOIETIC STEM CELLS AND PROMOTES THE CONVERGENT EVOLUTION OF THERAPY-RELATED CLONAL HEMATOPOIESIS

• Hidetaka Uryu,
• Koichi Saeki,
• Jyoti Nangalia,
• Michael Chapman,
• LI Zhao,
• Joanne Hsu,
• Carlos Bueso-Ramos,
• Shujuan Chen,
• Hui Yang,
• Courtney Dinardo,
• Naval Daver,
• Simona Colla,
• Irene Ganan-Gomez,
• Jianhua Zhang,
• Xingzhi Song,
• Erika Thompson,
• Hongli Tang,
• Robert Z Orlowski,
• Richard E. Champlin,
• Muzaffar H. Qazilbash,
• Elizabeth J. Shpall,
• Andrew Futreal,
• Guillermo Garcia-Manero,
• Hiroshi Haeno,
• Koichi Takahashi

Affiliations

Hidetaka Uryu

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Koichi Saeki

2 Tokyo University of Science Noda Campus, Division of Integrated Research, Research Institute for Biomedical Sciences, Noda, Japan

Jyoti Nangalia

3 Wellcome Sanger Institute, Hinxton, United Kingdom

Michael Chapman

3 Wellcome Sanger Institute, Hinxton, United Kingdom

LI Zhao

4 The University of Texas MD Anderson Cancer Center, Department of Genomic Medicine, Houston, United States

Joanne Hsu

5 Harvard Medical School, Boston, United States

Carlos Bueso-Ramos

6 The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, United States

Shujuan Chen

4 The University of Texas MD Anderson Cancer Center, Department of Genomic Medicine, Houston, United States

Hui Yang

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Courtney Dinardo

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Naval Daver

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Simona Colla

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Irene Ganan-Gomez

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Jianhua Zhang

4 The University of Texas MD Anderson Cancer Center, Department of Genomic Medicine, Houston, United States

Xingzhi Song

4 The University of Texas MD Anderson Cancer Center, Department of Genomic Medicine, Houston, United States

Erika Thompson

7 The University of Texas MD Anderson Cancer Center, Department of Genetics, Houston, United States

Hongli Tang

7 The University of Texas MD Anderson Cancer Center, Department of Genetics, Houston, United States

Robert Z Orlowski

8 The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States

Richard E. Champlin

9 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

Muzaffar H. Qazilbash

9 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

Elizabeth J. Shpall

9 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

Andrew Futreal

4 The University of Texas MD Anderson Cancer Center, Department of Genomic Medicine, Houston, United States

Guillermo Garcia-Manero

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Hiroshi Haeno

2 Tokyo University of Science Noda Campus, Division of Integrated Research, Research Institute for Biomedical Sciences, Noda, Japan

Koichi Takahashi

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States